Overall survival with warfarin versus low-molecular-weight heparin in cancer-associated thrombosis

被引：0
|
作者：
Patell, R. [1 ,2 ]
Chiasakul, T. [1 ,2 ,3 ,4 ]
Redd, R. [5 ]
Khan, A. M. [1 ,2 ]
McCarthy, E. P. [6 ,7 ,8 ]
Neuberg, D. [5 ]
Zwicker, J. I. [1 ,2 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol, Boston, MA 02115 USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Hemostasis & Thrombosis, Boston, MA 02115 USA
[3] Chulalongkorn Univ, Fac Med, Dept Med, Div Hematol, Bangkok, Thailand
[4] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
[5] Dana Farber Canc Inst, Boston, MA USA
[6] Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Boston, MA USA
[7] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Gerontol, Boston, MA 02115 USA
[8] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med, Boston, MA 02115 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 200卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-97
引用
收藏
页码：S72 / S73
页数：2
相关论文
共 50 条
  • [31] LOW-MOLECULAR-WEIGHT HEPARIN FOR VENOUS THROMBOSIS IN A NEONATE
    DZUMHUR, SM
    GOSS, DE
    COHEN, AT
    LANCET, 1995, 346 (8988): : 1487 - 1487
  • [32] LOW-MOLECULAR-WEIGHT HEPARIN IN PREVENTION OF PERIOPERATIVE THROMBOSIS
    LEIZOROVICZ, A
    HAUGH, MC
    CHAPUIS, FR
    SAMAMA, MM
    BOISSEL, JP
    BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6859): : 913 - 920
  • [33] Occurrence and management of thrombosis recurrence and bleeding in low-molecular-weight heparin-treated patients with cancer-associated thrombosis: a French nationwide cohort study
    Mah, Isabelle
    Gusto, Gaelle
    Quignot, Nadia
    Khachatryan, Artak
    Chaves, Jose
    Moniot, Audrey
    Andre, Lucas
    Van Roy, Sylvain
    Mokgokong, Ruth
    Bertoletti, Laurent
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (01)
  • [34] Bridging low-molecular-weight heparin for temporary interruption of warfarin
    Shojania, A. M.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (09) : 671 - 671
  • [35] Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis
    Soff, Aaron P.
    Dong, Judy
    Dong, Aiqi
    Devlin, Sean
    Mantha, Simon
    Parameswaran, Rekha
    Soff, Gerald A.
    BLOOD, 2015, 126 (23)
  • [36] Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism
    Linkins, Lori-Ann
    BMJ EVIDENCE-BASED MEDICINE, 2018, 23 (06) : 230 - 230
  • [37] Hirudin versus heparin and low-molecular-weight heparin: And the winner is ...
    Hull, RD
    Pineo, GF
    Raskob, GE
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (03): : 171 - 174
  • [38] The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects - Low-molecular-weight heparin versus unfractionated heparin
    Hull, RD
    Pineo, GF
    Raskob, GE
    HAEMOSTASIS, 1998, 28 : 8 - 16
  • [39] THROMBOCYTOPENIA ASSOCIATED WITH LOW-MOLECULAR-WEIGHT HEPARIN
    EICHINGER, S
    KYRLE, PA
    BRENNER, B
    WAGNER, B
    KAPIOTIS, S
    LECHNER, K
    KORNINGER, HC
    LANCET, 1991, 337 (8754): : 1425 - 1426
  • [40] Thrombocytosis associated with low-molecular-weight heparin
    Rizzieri, DA
    Wong, WM
    Gockerman, JP
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (02) : 157 - 157
12345